Product NDC: | 75935-001 |
Proprietary Name: | LAVIV |
Non Proprietary Name: | azficel-T |
Active Ingredient(s): | 15000000 1/mL & nbsp; azficel-T |
Administration Route(s): | INTRADERMAL |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 75935-001 |
Labeler Name: | Fibrocell Technologies, Inc. |
Product Type: | CELLULAR THERAPY |
FDA Application Number: | BLA125348 |
Marketing Category: | BLA |
Start Marketing Date: | 20110715 |
Package NDC: | 75935-001-01 |
Package Description: | 2 VIAL in 1 PACKAGE (75935-001-01) > 1 mL in 1 VIAL (75935-001-02) |
NDC Code | 75935-001-01 |
Proprietary Name | LAVIV |
Package Description | 2 VIAL in 1 PACKAGE (75935-001-01) > 1 mL in 1 VIAL (75935-001-02) |
Product NDC | 75935-001 |
Product Type Name | CELLULAR THERAPY |
Non Proprietary Name | azficel-T |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRADERMAL |
Start Marketing Date | 20110715 |
Marketing Category Name | BLA |
Labeler Name | Fibrocell Technologies, Inc. |
Substance Name | AZFICEL-T |
Strength Number | 15000000 |
Strength Unit | 1/mL |
Pharmaceutical Classes | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Fibroblasts [Chemical/Ingredient] |